FDG-PET/CT in the Evaluation of Patients With Suspected Cholecystitis
Completed · Not applicable
Conditions studied: Cholecystitis
In brief
This is a pilot study to investigate the ability of fluorodeoxyglucose-positron emission tomography (FDG-PET) and Positron emission tomography-computed tomography (PET/CT) as a direct method of detecting infection and/or inflammation of the gallbladder.
Key facts
- Study ID
- NCT00590395
- Run by
- Alan D. Waxman, M.D.
- People needed
- 19
- Starts
- 2007-07-01
- Expected to finish
- 2010-07-01
- Last updated by the study team
- 2019-12-10
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- known or high suspicion of cholecystitis
- highly likely to undergo cholecystectomy
- positive HIDA study
- age >18 years old
- provide written informed consent
You may not qualify if…
- highly unlikely to proceed to surgery or biopsy
- received an investigational drug within the past 30 days
- pregnant or lactating
- decline to provide written informed consent
Where it is running
- Cedars-Sinai Medical Center, S. Mark Taper Foundation Imaging Center — Los Angeles, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.